Sunday, August 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth AcceleratestodayMarketHugel Posts Record H1 Revenue on Overseas Toxin Surge3 days agoDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion DemandtodayMarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%3 days agoInjectablesGalderma Wins EU Nod for Restylane ShaypeyesterdayBusiness & M&AEstablishment Labs Raises 2026 Revenue Guidance2 days agoDevices & TechMerz Ultherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&ABeauty Health Q2 Earnings: Device Demand Steady2 days agoInjectablesHugel Debuts Thechaum Signature with Reduced CrosslinkeryesterdayDevices & TechAlma Launches TitaniumLift™ Multi-Depth RF Protocol2 days agoInjectablesGLP-1 Boom Exposed Filler Limitations—Here's WhyyesterdayInjectablesGalderma Chief: Start GLP-1 Patients on Skin Care First2 days ago
Sector Catalysts

CHIPS Act

Federal law funding domestic semiconductor manufacturing with grants and tax credits to reshore chip supply.

Also known as: CHIPS and Science Act, Chip Subsidies

What it is
The CHIPS and Science Act provides federal grants, loans, and an investment tax credit to expand U.S. semiconductor manufacturing and research. Commerce administers the funding awards. It aims to reduce reliance on foreign fabrication.
What it does
CHIPS awards and the manufacturing tax credit subsidize fab construction, benefiting chipmakers and their equipment and construction suppliers. Award announcements are single-name catalysts. It anchors a multi-year domestic buildout theme.
The evidence
Announced CHIPS grants to leading chipmakers have flagged multi-year fab buildouts benefiting equipment and materials suppliers.
Best for
Fabs and equipment: INTC, TSM, MU, AMAT, LRCX.
Pairs well with
export-controls, ira-tax-credits, reconciliation
Use cautiously with
Grants are milestone-based and slow; assuming award headlines equal near-term earnings overstates the timing.
Cautions
Fab payoffs are years out and depend on end-market demand cycles.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More sector catalysts

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →